Brind.

Tempus listed on the NASDAQ stock exchange, providing diagnostic data and AI tools to facilitate drug approval processes.

Steady: 0 in the last 7 days Updated oct 12

The latest in this situation

  1. Cantor Fitzgerald initiated coverage on Tempus AI shares, which is listed on Nasdaq.
  2. Tempus is seeking expanded Medicare reimbursement revenue following its listing on Nasdaq.

How it started

9 reports, 3 independent, last reported Oct 17. The briefing below covers this first event.

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 3 independent outlets

Tempus listed on the NASDAQ stock exchange, providing diagnostic data and AI tools to facilitate drug approval processes.

Who's involved

What this event is mainly about
TempusNasdaq

How it developed

Newest first. Tap a step to see who reported it.
  1. Cantor Fitzgerald initiated coverage on Tempus AI shares, which is listed on Nasdaq.1 source
  2. Tempus listed on Nasdaq, filed disclosures with the SEC, and received research reports from Jefferies Financial Group.Sub-event
  3. Tempus IPO on NASDAQ highlights its role in AI diagnostics and drug approval.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
4 more outlets ran the same wire story